BIOLASE, Inc. (BIOL)

Market Cap	634.96K
Revenue (ttm)	46.10M
Net Income (ttm)	-26.81M
Shares Out	36.60M
EPS (ttm)	-1.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,672,966
Open	0.0490
Previous Close	0.0630
Day's Range	0.0157 - 0.0520
52-Week Range	0.0157 - 1.9400
Beta	0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About BIOLASE

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; di...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 157
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIOL

Financial Performance

In 2023, BIOLASE's revenue was $49.16 million, an increase of 1.45% compared to the previous year's $48.46 million. Losses were -$37.62 million, 30.4% more than in 2022.